GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
Ontology highlight
ABSTRACT: G protein-coupled receptors (GPCRs) are the most widely targeted gene family for Food and Drug Administration (FDA)-approved drugs. To assess possible roles for GPCRs in cancer, we analyzed The Cancer Genome Atlas (TCGA) data for mRNA expression, mutations, and copy number variation (CNV) in 20 categories and 45 subtypes of solid tumors and quantified differential expression (DE) of GPCRs by comparing tumors against normal tissue from the Gene Tissue Expression Project (GTEx) database. GPCRs are overrepresented among coding genes with elevated expression in solid tumors. This analysis reveals that most tumor types differentially express >50 GPCRs, including many targets for approved drugs, hitherto largely unrecognized as targets of interest in cancer. GPCR mRNA signatures characterize spe
SUBMITTER: Sriram K
PROVIDER: S-EPMC6901242 | biostudies-literature | 2019 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA